Showing results (121-130 of 153) with videos related to

Sort By:
Pageof 16
Esophagus : Official Journal of the Japan Esophageal Society|April 3, 2024
Japanese Classification of Esophageal Cancer, 12th Edition: Part IShinji Mine, Koji Tanaka, Hiroshi Kawachi, et al.
Esophagus : Official Journal of the Japan Esophageal Society|November 18, 2022
First-line nivolumab plus ipilimumab or chemotherapy versus chemotherapy alone in advanced esophageal squamous cell carcinoma: a Japanese subgroup analysis of open-label, phase 3 trial (CheckMate 648/ONO-4538-50)Ken Kato, Yuichiro Doki, Takashi Ogata, et al.
International Journal of Oncology|January 17, 2009
Resistance to paclitaxel therapy is related with Bcl-2 expression through an estrogen receptor mediated pathway in breast cancerYoko Tabuchi, Junji Matsuoka, Mehmet Gunduz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 17, 2008
Dual tyrosine kinase inhibitor for focal adhesion kinase and insulin-like growth factor-I receptor exhibits anticancer effect in esophageal adenocarcinoma in vitro and in vivoNobuyuki Watanabe, Munenori Takaoka, Kazufumi Sakurama, et al.
Cancer Chemotherapy and Pharmacology|January 1, 2018
A multi-institution phase II study of docetaxel and S-1 in combination with trastuzumab for HER2-positive advanced gastric cancer (DASH study)Shunsuke Kagawa, Atsushi Muraoka, Takeshi Kambara, et al.
Histopathology|July 27, 2010
Preferential up-regulation of heparanase and cyclooxygenase-2 in carcinogenesis of Barrett's oesophagus and intestinal-type gastric carcinomaRyotaro Sonoda, Yoshio Naomoto, Yasuhiro Shirakawa, et al.
Langenbeck'S Archives of Surgery|January 18, 2006
Colonic interposition and supercharge for esophageal reconstructionYasuhiro Shirakawa, Yoshio Naomoto, Kazuhiro Noma, et al.
Cancers|October 29, 2025
Tertiary Lymphoid Structures Are Associated with Favorable Clinical Outcomes and Negatively Correlated with Cancer-Associated Fibroblasts in Esophageal CancerTomoyoshi Kunitomo, Kazuhiro Noma, Noriyuki Nishiwaki, et al.
Cancer Biology & Therapy|January 8, 2013
Antiproliferative effect of a novel mTOR inhibitor temsirolimus contributes to the prolonged survival of orthotopic esophageal cancer-bearing miceToshio Nishikawa, Munenori Takaoka, Toshiaki Ohara, et al.
Oncology Reports|March 6, 2010
RAD001 offers a therapeutic intervention through inhibition of mTOR as a potential strategy for esophageal cancerZhi Gang Wang, Takuya Fukazawa, Toshio Nishikawa, et al.
Pageof 16